期刊文献+

胃癌中Notch1、DLL4、HES-1表达与微血管、微淋巴管生成的关系及意义 被引量:1

Relationships between Notch1, DLL4, HES-1 expression and angiogenesis, lymphangiogenesis of gastric carcinoma and their significances
原文传递
导出
摘要 目的 研究Notch1、Delta样分子4(DLL4)、发状分裂相关增强子-l(HES-1)在胃癌组织的表达检测微血管密度(MVD)和微淋巴管密度(MLD),探讨它们在胃癌发生发展中的作用.方法 收集术后切除的胃癌组织、距癌组织边缘>60mm的癌旁组织,同期胃镜下正常胃黏膜作为对照.将标本组织制作组织芯片,用免疫组织化学染色法检测Notch1、DLL4和HES-1表达,免疫组织化学双染法检测MVD和MLD,分析Notch1、DLL4和HES-1表达与微血管、微淋巴管生成的关系及意义.结果 Notch1在胃癌组的阳性率为48.30%,显著高于癌旁组(25.00%,χ2 =6.38,P<0.05)和对照组(16.67%,χ2=10.18,P<0.05);DLL4在胃癌组的阳性表达率为55.94%,与癌旁组(45.70%)和对照组(56.67%)之间的差异均无统计学意义(χ2=1.18,P>0.05χ2=0.005,P>0.05);HES-1在胃癌组的阳性率为36.64%,与癌旁组(34.40%)和对照组(33.3%)之间差异无统计学意义(χ2=0.05,P>0.05;χ2=0.11,P>0.05).胃癌组MVD为28.84±14.17,高于癌旁组(17.02±8.54,t =4.03,P<0.05)和对照组(16.69 ±7.21,=5.01,P<0.05);胃癌组MLD为8.55 ±4.98,显著高于癌旁组(4.05 ±2.48,=9.30,P<0.05)和对照组(3.99±1.56,t=10.32,P<0.05).DLL4表达与MVD有相关性(t=2.77,P<0.05),与MLD无相关性(t=1.89,P>0.05).Notch1和HES-1表达与MVD和MLD之间无相关性(P>0.05).结论 Notch1在胃癌发展中具重要作用;胃癌中存在大量新生微血管、微淋巴管;胃癌中DLL4的表达在促进微血管的形成中有一定作用. Objective To investigate the expression of Notchl, Delta-like ligand 4 ( DLIA), hairy and enhancer of split-1 (HES-1), mierovessel density (MVD), lymphatic vessel density (MLD) in gastric carcino- ma, so as to discuss their roles in the development of gastric carcinoma. Methods Gastric carcinoma, paracan- cer tissues which was apart from the edge of cancer tissue 〉 60 mm obtained during operation and normal gastric mucosa obtained during gastroscopy were used as controls. All specimens were made tissue microarray. The ex- pressions of Notchl, DLL4, HES-1 were detected by immunohistochemistry. Immunohistoehemical double taining was used to detect MVD and MLD. The relationships between Notchl, DLL4, HES-1 expression and angiogene- sis, lymphangiogenesis and their significances were analyzed. Results The positive rate of Notchl in gastric car- cinoma was 48.30% , significantly higher than that of paracancerous ( 25.00% ,χ2 = 6.38, P 〈 0.05 ) and control group (16.67% ,χ2 = 10. 18, P 〈 0.05). The differences of the positive rate of DLL4 in gastric carcinoma (55. 94% ), paraeancerous (45.70%) and control group (56.67%) were not significant (χ2 = 1.18, P 〉0.05 ; χ2 = 0. 005, P 〉 0.05 ). The differences of the positive rate of HES-1 in gastric carcinoma (36.64%), paracancerous( 34.40% ) and control group ( 33.33% ) were not significant (χ2 = 0.05, P 〉 0.05 ; χ2 = 0.11, P 〉 0. 05 ). The mean of MVD in gastric carcinoma group was 28.84 ± 14.17, which was significantly higher than that in paracan- cerous group ( 17.02 ± 8.54, t = 4.03, P 〈 0.05 ) and control group ( 16.69± 7.21, t = 5.01, P 〈 0.05 ). The mean of MLD in gastric carcinoma group was 8.55 ±4.98, which was significantly higher than that in paracancerousgroup (4.05±2.48, t=9.30, P〈0.05) and control group (3.99 ±1.56, t=10.32, P〈0.05). The ex- pression of DLL4 was correlated with MVD ( t = 2.77, P 〈 0.05 ), but wasn't correlated with MLD ( t = 1.89, P 〉 0.05 ). There were no correlations between the expression of Notchl, HES-1 and tissues MVD, MLD (P 〉 0. 05 ). Conclusion Notchl plays important roles in the development of gastric carcinoma. There are many anglo- genesis and lymphangiogenesis in gastric carcinoma. The expression of DLL4 in gastric carcinoma has certain effect in the formation of microvessel.
出处 《国际肿瘤学杂志》 CAS 2014年第10期789-792,共4页 Journal of International Oncology
基金 甘肃省科技支撑计划(1011FKCA120)
关键词 胃肿瘤 受体 Notch1 淋巴管 微血管 Delta样分子4 发状分裂相关增强子-1 Stomach neoplasms Receptor, Notchl Lymphatic vessels Microvessels DLIA HES-1
  • 相关文献

参考文献4

二级参考文献57

  • 1王启俊,祝伟星,袁光亮.2001年北京地区癌症死亡预测[J].中华流行病学杂志,1995,16(4):195-198. 被引量:6
  • 2Martinez JC,Muller MM,Turley H,et al.Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4(DLIA) in normal and malignant human tissues.Histopathology,2009,54 (5):598-606.
  • 3Ridgway J,Zhang G,Wu Y,et al.Inhibition of Dll4 signalling inhibits tumour growth by deregulating angingenesis.Nature,2006,444(7122):1083-1087.
  • 4Li JL,Harris AL.Crosstalk of VEGF and Notch pathways in tumour angiogenesis:therapeutic implications.Front Biesci,2009,14(1):3094-3110.
  • 5Li JL,Sainson RC,Shi W,et al.Delta-like 4 Notch ligend regulates tumor angiogenesis,improves tumor vascular function,and promotes tumor growth in vivo.Cancer Res,2007,67(23):11244-11253.
  • 6Thurston G,Kitajewski J.VEGF and Delta-Notch:interacting signalling pathways in tumour angiogenesis.Br J Cancer,2008,99 (8):1204-1209.
  • 7Duda DG,Batchelor TT,Willett CG,et al.VEGF-targeted cancer therapy strategies:current progress,hurdles and future prospects.Trends Mol Med,2007,13(6):223-230.
  • 8Segarta M,Williams CK,Sierra Mde L,et al.Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth.Blood,2008,112(5):1904-1911.
  • 9Bray SJ.Notch signalling:a simple pathway becomes complex.Nat Rev Mol Cell Biol,2006,7(9):678-689.
  • 10Cristofaro B,Emanueli C.Possible novel targets for therapeutic angiogenesis.Curr Opin Pharmacol,2009,9(2):102-108.

共引文献362

同被引文献17

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部